(12) United States Patent (10) Patent N0.: US 8,283,294 B2 Kastrup Et A]
Total Page:16
File Type:pdf, Size:1020Kb
US008283294B2 (12) United States Patent (10) Patent N0.: US 8,283,294 B2 Kastrup et a]. (45) Date of Patent: Oct. 9, 2012 (54) METHOD FOR CLONING COGNATE FOREIGN PATENT DOCUMENTS ANTIBODIES FR 2724393 3/1996 W0 WO 92/15678 Al 9/1992 (75) Inventors: Jesper Kastrup, Stenlose (DK); Lars S. W0 WO 93/03151 Al 2/1993 Nielsen, Niva (DK); Per-Johan Meijer, W0 WO 93/20227 A1 10/1993 Copenhagen (DK) W0 WO 94/08008 Al 4/1994 W0 WO 95/20401 Al 8/1995 (73) Assignee: Symphogen A/S, Lyngby (DK) W0 WO 96/08564 Al 4/1996 W0 WO 98/57994 A2 12/1998 ( * ) Notice: Subject to any disclaimer, the term of this W0 WO 99/16904 Al 4/1999 patent is extended or adjusted under 35 W0 WO 99/29888 Al 5/1999 U.S.C. 154(b) by 122 days. W0 WO 01/89563 A1 11/2001 W0 WO 01/92291 A2 12/2001 (21) Appl.No.: 12/074,066 WO 2004/003019 * 6/2004 (22) Filed: Feb. 29, 2008 W0 WO 2004/061104 A2 7/2004 (65) Prior Publication Data W0 WO 2005/042774 A2 5/2005 W0 WO 2006/007850 Al l/2006 US 2008/0227660 A1 Sep. 18, 2008 W0 WO 2006/007853 A2 l/2006 W0 WO 2007/003041 Al l/2007 W0 WO 2007/101441 Al l/2007 Related US. Application Data W0 WO 2007/065433 A2 6/2007 (60) Provisional application No. 60/904,772, ?led on Mar. OTHER PUBLICATIONS 5, 2007. Rudikoff et al (Proc Natl Acad Sci USA 1982 vol. 79 p. 1979).* Ward et al. (Nature 341:544-546 (1989)).* (30) Foreign Application Priority Data Smith-Gill et al. (J. Immunol. 139:4135-4144 (1987)).* Kumar et al. (J. Biol. Chem. 275:35129-35136 (2000)).* Mar. 1, 2007 (DK) ............................... .. 2007 00316 Song et al. (Biochem Biophys Res Comm 268:390-394 (2000)).* Soderlind et al. (Gene 160:269-272 (1995).* (51) Int. Cl. Soderlind et al. (Immunotechnology 4:279-285 (Mar. 1999).* Ardavin, C., et al., “B Cell Response After MMTV Infection: C40B 40/08 (2006.01) Extrafollicular Plasmablasts Represent the Main Infected Population C40B 50/06 (2006.01) and Can Transmit Viral Infection,” J'. Immunol. 162:2538-2545, The (52) US. Cl. ........................ .. 506/17; 506/26; 424/133.1 American Association of Immunologists (1999). (58) Field of Classi?cation Search .................. .. 506/17, Babcook, 18., et al., “A novel strategy for generating monoclonal antibodies from single, isolated lymphocytes producing antibodies of 506/26; 424/133.1 de?ned speci?cities,” Proc. Natl. Acad. Sci. USA 93:7843-7848, See application ?le for complete search history. National Academy of Science (1996). Bregenholt, S., et al., “Recombinant Human Polyclonal Antibodies: (56) References Cited A New Class of Therapeutic Antibodies Against Viral Infections,” Curr". Pharm. Des. 12:2007-2015, Bentham Science Publishers (Jan. U.S. PATENT DOCUMENTS 2006). Haurum, J.S., “Recombinant polyclonal antibodies: the next genera 4,683,202 A 7/1987 Mullis 5,698,435 A 12/1997 Robinson et al. tion of antibody therapeutics?,” Drug Discov. Today 11:655-660, 5,882,856 A 3/1999 Shuber Elsevier Science (Jul. 2006). 5,912,172 A 6/1999 Eshhar et a1. Liu, A.Y., et al., “Expression of mousezzhuman immunoglobulin 6,096,878 A 8/2000 Honjo et a1. heavy-chain cDNA in lymphoid cells,” Gene 54:33-40, Elsevier Sci 6,111,166 A 8/2000 van de Winkel ence (1987). 6,258,529 B1 7/2001 BerdoZ et al. Liu, M.-L., et al., “Chronic idiopathic myelo?brosis terminating in 6,538,124 B1 3/2003 Idusogie et al. extramedullary anaplastic plasmacytoma,”Leuk. Lymphoma 47:315 6,849,259 B2 2/2005 Haurum et al. 322, Taylor & Francis (Feb. 2006). 6,867,021 B2 3/2005 Maes et a1. 6,994,963 B1 2/2006 Murphy et a1. (Continued) 7,749,697 B2 7/ 2010 OleksieWicZ et al. Primary Examiner * Lynn Bristol 2001/0027249 A1 10/2001 Le et al. 2002/0102604 A1 8/ 2002 Milne Edwards et a1. (74) Attorney, Agent, or Firm * Sterne, Kessler, 2003/0096343 A1 5/ 2003 Robinson et al. Goldstein & Fox P.L.L.C. 2003/0104477 A1 6/ 2003 Buechler et al. (57) ABSTRACT 2003/0175837 A1 9/2003 Le et al. 2004/0067532 A1 4/2004 Zhu et al. The invention relates to a procedure for linking cognate pairs 2005/0180967 A1 8/ 2005 Haurum et al. ofVH and VL encoding sequences from a population of cells 2006/0228350 A1 10/2006 Wu et al. enriched in particular surface antigen markers. The linking 2006/0275766 A1 12/2006 Haurum et al. procedure involves a multiplex molecular ampli?cation pro 2007/0003515 A1 l/2007 Leonard et a1. cedure capable of linking nucleotide sequences of interest in 2007/0141048 A1 6/2007 OleksieWicZ et al. 2008/0069822 A1 3/2008 Jensen et al. connection With the ampli?cation, in particular polymerase 2008/0131882 A1 6/2008 Rasmussen et al. chain reaction (multiplex PCR). The method is particularly 2008/0226630 A1 9/2008 Lantto et a1. advantageous for the generation of cognate pair libraries as 2009/0004192 A1 l/ 2009 Pedersen et al. Well as combinatorial libraries of variable region encoding 2009/0017017 A1 l/2009 Rasmussen et al. sequences from immunoglobulins. The invention also relates 2009/0111142 A1 4/ 2009 Nielsen et al. to methods for generation of chimeric human/non-human 2009/0136498 A1 5/ 2009 Haurum et al. antibodies and expression libraries generated by such meth 2009/0137003 A1 5/ 2009 Tolstrup et al. ods. 2010/0069262 A1 3/ 2010 Nielsen et al. 2010/0310558 A1 12/ 2010 OleksieWicZ et al. 36 Claims, 8 Drawing Sheets US 8,283,294 B2 Page 2 OTHER PUBLICATIONS Database Biotechno, Accession No. 1999129223369, Abstract for Logtenberg, T., “Antibody cocktails: next-generation Tanabe, R., et al., “Expression of myosin heavy chain isoforms in biopharmaceuticals with improved potency,” Trends Biotechnol. porcine muscles determined by multiplex PCR,” Journal of Food 251390-394, Elsevier Science (Sep. 2007). Science 641222-225, Institute of Food Technologists, US (1999). Database Biotechno, Accession No. 1999129445017, Abstract for Meijer, P.-R., et al., “Isolation of Human Antibody Repertoires with Cheng, L., et al., “Expression in normal human tissues of ?ve Preservation of the Natural Heavy and Light Chain Pairing,” .1. Mol. nucleotide excision repair genes measured simultaneously by multi Biol. 3581764-772, Elsevier Science (May 2006). plex reverse transcription-polymerase chain reaction,” Cancer Epi Orlandi, R., et al., “Cloning immunoglobulin variable domains for demiology Biomarkers and Prevention 81801-807, American Asso expression by the polymerase chain reaction,” Proc. Natl. Acad Sci. ciation for Cancer Research, US (1999). USA 8613833-3837, National Academy of Science (1989). de Haard, H. et al., “A Large Non-immunized Human Fab Fragment Poulsen, T.R., et al., “Kinetic, Af?nity, and Diversity Limits of Phage Library That Permits Rapid Isolation and Kinetic Analysis of Human Polyclonal Antibody Responses against Tetanus Toxoid,” .1. High Af?nity Antibodies,” .1. Biol. Chem. 274118218-18230, The American Society for Biochemistry and Molecular Biology, Inc., US Immunol. 1 7913841-3850, The American Association of Immunolo (1999). gists (Sep. 2007). de Wildt, R. et al., “Antibody arrays for high-throughput screening of Requena, L., “Afectacion cutanea especi?ca en pacientes con antibody-antigen interactions,” Nat. Biotechnol. 181989-994, Nature mieloma multiple. Estudio clinico-patologico, inmunohistoquimico America Inc., US (2000). y citogenético de 40 casos,” Actas Dermosi?liogr 961424-440, Den W. et al., “A bidirectional phage display vector for the selection Doyma (2005). and mass transfer of polyclonal antibody libraries,” .1. Immunol. STNEasy Database, English language abstract of Requena, L.,Actas Meth. 222145-57, Elsevier Science B.V., UK (1999). Dermosi?liogr 96:424-440. Embleton, M. et al., “In-cell PCR from mRNA: amplifying and Requena, L., et al., “Cutaneous Involvement in Multiple Myeloma: A linking the rearranged immunoglobulin heavy and light chain Clinicopathologic, Immunohistochemical, and Cytogenetic Study of V-genes within single cells,” Nucleic Acids Res. 201383 1-3 837, 8 Cases,”Arch Dermatol. 1391475-486, American Medical Associa Oxford University Press, UK (1992). tion (2003). Fitzgerald, K., “In vitro display technologiesinew tools for drug Sharon, J ., et al., “Recombinant Polyclonal Antibodies for Cancer discovery,” Drug Discovery Today 51253-258, Elsevier Science Ltd., Therapy,” .1. Cell. Biochem. 961305-313, Wiley-Liss (2005). UK (2000). Tolstrup, A.B., et al., “Development of recombinant human Gherardi, E. and Milstein, C., “Original and arti?cial antibodies,” polyclonal antibodies for the treatment of complex human diseases,” Nature 3571201-202, Nature Publishing Group, UK (1992). Expert Opin. Biol. Ther. 61905-912, Ashley Publications (Sep. 2006). Guatelli, J. et al., “Isothermal, in vitro ampli?cation of nucleic acids Weissenhorn, W., et al., “Chimerization of antibodies by isolation of by a multienzyme reaction modeled after retroviral replication,” rearranged genomic variable regions by the polymerase chain reac Proc. Natl. Acad Sci. USA 8711874-1878, The National Academy of tion,” Gene 1061273-277, Elsevier Science (1991). Sciences, US (1990). Wiberg, F.C., et al., “Production of Target-Speci?c Recombinant Harris, E. et al., “Typing of Dengue Viruses in Clinical Specimens Human Polyclonal Antibodies in Mammalian Cells,” Biotechnol. and Mosquitoes by Single-Tube Multiplex Reverse Transcriptase Bioeng. 941396-405, Wiley (Jun. 2006). PCR,” .1 Clin Microbiol. 36(9): 2634-9, American Society for Altman, J. et al., “Phenotypic Analysis of Antigen-Speci?c T Lyrn Microbiology, US (Sep. 1998). phocytes,” Science 274194-96, American Association for the Henegariu, O. et al., “Multiplex PCR: Critical Parameters and Step Advancement of Science, US (1996). by-Step Protocol,” BioTechniques 231504-51 1, Eaton Publishing Barbas, C. et al., “Assembly of combinatorial antibody libraries on Company, US (1997).